CELL THERAPEUTICS INC's ticker is CTIC and the CUSIP is 150934883. A total of 62 filers reported holding CELL THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2013 | $12,000 | – | 11,470 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rotella Capital Management, Inc. | 27,000 | $28,000 | 0.09% |
Del Mar Asset Management, LP | 95,967 | $100,000 | 0.06% |
First Heartland Consultants, Inc. | 74,624 | $78,000 | 0.04% |
Geduld E E | 50,000 | $53,000 | 0.04% |
Alpine Partners USVI, LLC | 90,017 | $94,000 | 0.03% |
CTC Alternative Strategies, Ltd. | 107,300 | $112,665,000 | 0.03% |
WASHINGTON TRUST Co | 259,659 | $273,000 | 0.02% |
KNIGHT CAPITAL GROUP LLC | 1,019,384 | $1,081,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 943,671 | $991,000 | 0.02% |
Jane Street Holding, LLC | 618,516 | $649,000 | 0.01% |